Coulter Partners announces top global hires for large-cap, mid-cap and public companies (H2-2024)
Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
CEO/ C-suite/ Board
· CEO, Medtech (publicly listed), APAC
· CEO, Life science tools (publicly listed), Nordics
· President Life Sciences, Specialty chemicals (large-cap), UK & Ireland
· Chief Financial Officer Biotech (publicly listed), US
· Chief Financial Officer, Biopharma/ drug delivery (publicly listed), UK & Ireland
· Chief of Staff , Biopharma (publicly listed), Europe
· Chair, Mental health pharma (publicly listed), US/ UK
Commercial / Functional / Strategic Leadership
· VP, Artificial Intelligence, Drug discovery (publicly listed), UK & Ireland
· Head of Corporate Business Development, Pharma (mid-cap), Europe
· Country Launch Distribution Head , Specialty pharma (mid-cap), Europe
· Head of Human Resources Europe, Pharma (publicly listed), US
· Country Head of Market Access, Platform technology (publicly listed), Europe
· Director, Innovation and New Technologies, Biopharma (publicly listed), UK & Ireland
· Country Senior Director, Pricing and Market Access, Biotech (large-cap), US/ UK
R&D/ Medical/ Technical
· EVP/ Head of R&D/ Chief Medical Officer, Diversified pharma (publicly listed), US
· VP, Inflammation Rheumatology, Pharma (large-cap), US
· VP, Technical Operations, Drug technologies (mid-cap), Europe
· VP, Head of Obesity Development, Pharma (large-cap), US
· VP, Global Medical Affairs, Oncology, Pharma (large-cap), US
· Head of Quality Management, Biopharma (mid-cap), Europe
· Country Director, Medical Affairs, Pharma (mid-cap), Europe
· Director, Clinical Research, Specialty pharma (mid-cap), Europe
· Medical Director, Biopharma (publicly listed), US
· Quality Affairs Director, Animal health (large-cap), Europe
